Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Nova Eye Medical Limited ELXMF

Full chart Compare
Set alert

Price alert · ELXMF

All alert types
0.01 USD 0.00 (+0.00%)

At closeNov 5, 2026, 4:00 PM EST

Day range unavailable

0.0019 52-week range 0.10
YTD
+653.16%
1 year
-85.69%

Financial health

Altman Z-Score

-1.20 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

C+2 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 5

Valuation

P/E -1.4×
FY 2017: -137×FY 2018: -17.5×FY 2019: -11.9×FY 2020: -12.8×FY 2021: -8.8×FY 2022: -0.2×FY 2023: -1.6×FY 2024: -3.5×FY 2025: -4.2×FY 2026: -1.4×
FY 2017 5y median -1.6× FY 2026
P/S 0.2×
FY 2017: 1.7×FY 2018: 1.1×FY 2019: 4.9×FY 2020: 7.0×FY 2021: 2.9×FY 2022: 0.1×FY 2023: 1.4×FY 2024: 1.3×FY 2025: 1.3×FY 2026: 0.2×
FY 2017 5y median 1.3× FY 2026
P/B 0.4×
FY 2017: 2.1×FY 2018: 1.2×FY 2019: 1.2×FY 2020: 0.9×FY 2021: 1.1×FY 2022: 0.0×FY 2023: 1.0×FY 2024: 1.4×FY 2025: 2.0×FY 2026: 0.4×
FY 2017 5y median 1.0× FY 2026
P/FCF -1.8×
FY 2017: -11.6×FY 2018: -41.9×FY 2019: -16.1×FY 2020: 23.7×FY 2021: -2.5×FY 2022: -0.1×FY 2023: -3.2×FY 2024: -3.7×FY 2025: -5.8×FY 2026: -1.8×
FY 2017 5y median -3.2× FY 2026
EV/EBITDA -3.3×
FY 2017: 85.1×FY 2018: -52.4×FY 2019: -18.7×FY 2020: 0.5×FY 2021: -7.0×FY 2022: 0.6×FY 2023: -1.9×FY 2024: -4.7×FY 2025: -5.3×FY 2026: -3.3×
FY 2017 5y median -3.3× FY 2026
EV/Sales 0.2×
FY 2017: 1.8×FY 2018: 1.0×FY 2019: 4.9×FY 2020: -0.2×FY 2021: 1.8×FY 2022: -0.3×FY 2023: 1.1×FY 2024: 1.2×FY 2025: 1.2×FY 2026: 0.2×
FY 2017 5y median 1.1× FY 2026
FCF Yield -57.0%
FY 2017: -8.6%FY 2018: -2.4%FY 2019: -6.2%FY 2020: 4.2%FY 2021: -39.5%FY 2022: -723.6%FY 2023: -31.3%FY 2024: -27.1%FY 2025: -17.2%FY 2026: -57.0%
FY 2017 5y median -31.3% FY 2026

Profitability

Gross Margin 71.7%
FY 2017: 57.0%FY 2018: 58.4%FY 2019: 81.6%FY 2020: -12.8%FY 2021: 13.2%FY 2022: -5.7%FY 2023: 4.9%FY 2024: 86.6%FY 2025: 64.5%FY 2026: 71.7%
FY 2017 5y median 64.5% FY 2026
Operating Margin -12.5%
FY 2017: -0.1%FY 2018: -4.4%FY 2019: -43.7%FY 2020: -56.2%FY 2021: -37.1%FY 2022: -49.2%FY 2023: -69.6%FY 2024: -38.4%FY 2025: -15.4%FY 2026: -12.5%
FY 2017 5y median -38.4% FY 2026
Net Margin -12.4%
FY 2017: -1.2%FY 2018: -6.4%FY 2019: -41.3%FY 2020: -54.7%FY 2021: -32.5%FY 2022: -56.0%FY 2023: -89.8%FY 2024: -37.7%FY 2025: -31.0%FY 2026: -12.4%
FY 2017 5y median -37.7% FY 2026
ROE -30.4%
FY 2017: -1.6%FY 2018: -6.9%FY 2019: -9.7%FY 2020: -7.0%FY 2021: -12.3%FY 2022: -24.7%FY 2023: -65.9%FY 2024: -41.2%FY 2025: -47.8%FY 2026: -30.4%
FY 2017 5y median -41.2% FY 2026
ROIC -26.2%
FY 2017: -0.1%FY 2018: -5.3%FY 2019: -9.6%FY 2020: -6.9%FY 2021: -10.5%FY 2022: -17.9%FY 2023: -43.1%FY 2024: -36.3%FY 2025: -20.5%FY 2026: -26.2%
FY 2017 5y median -26.2% FY 2026
ROA -20.1%
FY 2017: -1.0%FY 2018: -4.9%FY 2019: -6.7%FY 2020: -6.0%FY 2021: -10.4%FY 2022: -20.5%FY 2023: -50.4%FY 2024: -29.4%FY 2025: -34.2%FY 2026: -20.1%
FY 2017 5y median -29.4% FY 2026

Growth (YoY)

Revenue 19.0%
FY 2017: -1.7%FY 2018: 10.6%FY 2019: -79.7%FY 2020: -20.9%FY 2021: 4.9%FY 2022: -0.1%FY 2023: 27.3%FY 2024: 37.0%FY 2025: 25.5%FY 2026: 19.0%
FY 2017 FY 2026
Operating Income 3.0%
FY 2017: -101.4%FY 2018: -4251.9%FY 2019: -99.9%FY 2020: -1.8%FY 2021: 30.8%FY 2022: -32.6%FY 2023: -79.9%FY 2024: 24.3%FY 2025: 49.8%FY 2026: 3.0%
FY 2017 FY 2026
EPS (diluted) 58.5%
FY 2017: -127.4%FY 2018: -397.4%FY 2019: -19.6%FY 2020: -4.9%FY 2021: 37.8%FY 2022: -71.2%FY 2023: -89.1%FY 2024: 54.9%FY 2025: 15.1%FY 2026: 58.5%
FY 2017 FY 2026
Free Cash Flow 48.0%
FY 2017: -11094.8%FY 2018: 79.9%FY 2019: -132.5%FY 2020: 176.8%FY 2021: -499.3%FY 2022: 32.1%FY 2023: 26.8%FY 2024: -10.4%FY 2025: 22.4%FY 2026: 48.0%
FY 2017 FY 2026

Financial Health

Current Ratio 1.7×
FY 2017: 1.7×FY 2018: 2.7×FY 2019: 2.0×FY 2020: 7.2×FY 2021: 5.6×FY 2022: 4.0×FY 2023: 2.3×FY 2024: 2.6×FY 2025: 2.4×FY 2026: 1.7×
FY 2017 5y median 2.4× FY 2026
Quick Ratio 1.2×
FY 2017: 0.9×FY 2018: 1.7×FY 2019: 1.1×FY 2020: 7.0×FY 2021: 5.0×FY 2022: 3.1×FY 2023: 1.7×FY 2024: 1.8×FY 2025: 1.8×FY 2026: 1.2×
FY 2017 5y median 1.8× FY 2026
Debt / Equity 0.2×
FY 2017: 0.3×FY 2018: 0.2×FY 2019: 0.2×FY 2020: 0.0×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.2×FY 2025: 0.2×FY 2026: 0.2×
FY 2017 5y median 0.2× FY 2026
Net Debt / EBITDA -0.6×
FY 2017: 4.2×FY 2018: 5.2×FY 2019: 0.1×FY 2020: 16.1×FY 2021: 4.1×FY 2022: 0.8×FY 2023: 0.6×FY 2024: 0.5×FY 2025: 0.3×FY 2026: -0.6×
FY 2017 5y median 0.5× FY 2026
Interest Coverage -28.4×
FY 2017: -0.2×FY 2018: -11.3×FY 2019: -7047×FY 2020: -114×FY 2021: -73.0×FY 2022: -103×FY 2023: -219×FY 2024: -128×FY 2025: -60.9×FY 2026: -28.4×
FY 2017 5y median -103× FY 2026

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 50.6%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -445.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026

Annual · latest fiscal year ends 2026-06-30